Breathing Device Lowers Blood Pressure

A new device analyzes breathing rate and pattern, interactively guiding the patient through breathing exercises that reduce breathing rate. These exercises relax the muscles that surround small blood vessels, and over time these effects allow blood to flow more easily, resulting in sustained lower blood pressure.

The device, called Resperate, is comprised of a computerized control box, a respiration sensor, and headphones. Resperate reduces the typical breathing rate of 16-18 breaths per minute to the therapeutic range of below 10 breaths per minute. After each exercise, breathing returns to a normal rate and pattern, but the beneficial effect on blood pressure accumulates. To achieve best results, it is recommended that the device be used for 15 minutes three or four times a week.

As with other exercises, notable results appear within approximately four-to-six weeks and maintain benefits with routine use. Resperate is an adjunctive treatment which can be used safely in conjunction with medication and lifestyle modifications such as diet and exercise. The device has been approved by the U.S. Food and Drug Administration (FDA) and has received the CE mark.

Results have shown a reduction of up to 36 points systolic and 20 points diastolic, with average reductions of 14 mm Hg systolic and 8 mm Hg diastolic. All reduction in blood pressure is in addition to any reductions achieved with other therapies such as medication, diet or exercise. Resperate is the product of Intercure (Lod, Israel).



Related Links:
Intercure